IRVINE, Calif., April 23, 2026 – Highlighting the firm’s extensive experience in IP protection and enforcement for some of the world’s most well-known fashion brands, Knobbe Martens has once again…
In a recent episode of The Space Hour podcast, Knobbe Martens partner Tom Cowan offered insights on the unique intellectual property (IP) challenges facing “dual-use” aerospace companies – those technology…
In the Law360 article “’Lion King’ Suit May Not Reign In Podcasting Legal Jungle,” Knobbe Martens Trademark and Brand Protection partner Jonathan Menkes shared insights on the legal foundations of…
IRVINE, Calif., April 20, 2026 – Knobbe Martens is pleased to share that partners Salima Merani, Ph.D., Jason Jardine, and Kimberly Miller, Ph.D. have been recognized as “Life Sciences Visionaries”…
March Federal Circuit Newsletter (Japanese) March Federal Circuit Newsletter (Chinese) Software Claims Failed Alice Step One Where Purported Improvements Were Not Claimed In Trustees Of Columbia University v. Gen Digital…
PTAB to Rehear Ex Parte Baurin: Revisiting the Interplay of Obviousness-Type Double Patenting and Patent Term Adjustment After Cellect and Allergan Daniel M. Mittelstein & Michael L. Fuller The PTO…
In their recent Inventors Digest article, Knobbe Martens lawyers Alistair McIntyre and Tom Cowan examine key developments in Section 101 patent eligibility, and offer practical guidance for inventors navigating complex…
IRVINE, Calif., April 10, 2026 – Knobbe Martens is proud to announce that the firm received multiple recognitions at the 2026 Managing IP Awards, including “IP Boutique Firm of the…
Key Takeaway: With the decline of inter partes review (IPR) proceedings and the significant increase in ex parte reexamination (EPR) proceedings, the U.S. Patent and Trademark Office (USPTO) is allowing…
Presenting as part of an LSI ’26 panel, Knobbe Martens partners Kregg Koch and Sabing Lee joined fellow panelists to explore the complexities of intellectual property management for commercial-stage technologies in the medtech industry, and the…
